Biolase, Inc. (BIOL) - Net Sales Margin

BIOLASE Inc. (BIOL) - corporate logo

Innovative American plants of BIOLASE, Inc. (BIOL) create advanced systems for painless dentistry. The net profit margin trend on the GURU.Markets chart clearly demonstrates these processes, where the latest value is recorded as -78.30. High demand for patented water-jet tissue cutting provides pricing power, although the current status of asset liquidation following bankruptcy determines the company's fundamental backdrop.

Biolase Inc. (BIOL) - Return on Sales by Net Profit from 07/04/2022 to 08/04/2024

Financial and market metric breakdowns for BIOLASE, Inc. (BIOL)

- share price and expert price forecast:
Summary company analytics:Biolase Inc. - BIOL
Manufactured product of Biolase Inc.

The Waterlase ecosystem creates high barriers to entry for competitors through physician certification and proprietary equipment. By analyzing the commercial profit margin of BIOLASE, Inc. (BIOL) on GURU.Markets, an investor assesses the monetization efficiency of this advantage. This metric is calculated as the ratio of net income to total revenue, measuring the profit share of every dollar earned. Growth in this metric confirms cost optimization and operational resilience. A stable trend guarantees business reliability during shifts in the market cycle.

Analysis of competing companies

BSX: Net Sales Margin|Return on Sales by Net Profit Edwards Lifesciences Corporation|RMD (ResMed Corporation) - Net Sales Margin|OmniPod (PODD) - Company Sales Margin|Net Sales Margin ZBH|Net Sales Margin coopercos.com (COO)|Net Sales Margin ALGN (aligntech.com)|Net Sales Margin Globus Medical Inc GMED|TMDX - Net Margin|ATEC: Net Margin|AORT (Artivion, Inc.) - Return on Sales by Net Profit|Enovis Corporation - Net Profit Rate|IART (Integra LifeSciences Inc.) - Net Sales Margin|Net Margin Establishment Labs Corp ESTA|Net Margin Beta Bionics, Inc. (BBNX)|IRADIMED CORPORATION (IRMD) - Net Profitability Margin|Embecta Health - Return on Sales by Net Profit|Net Sales Margin Tandem Diabetes Care TNDM|AxoGen Inc - Net Sales Margin|Company Sales Margin SI-BONE Inc SIBN|Orthofix (OFIX) - Net Margin|Return on Sales by Net Profit Bioventus Corp|Net Margin orthopediatrics.com|Return on Sales by Net Profit Treace Medical Concepts (TMCI)|Net Sales Margin SRTA|CARL - Net Margin|Net Margin RxSight, Inc. RXST|CLPT: Net Return on Sales|STXS: Return on Sales by Net Profit|neurostar.com - Company Net Profitability|Sight Sciences Inc. (SGHT) - Net Margin|Net Margin orchestrabiomed.com (OBIO)|Net Margin Anika Therapeutics, Inc.|Net Return on Sales NSPR (InspireMD Inc.)|Net Margin Jin Medical International Ltd (ZJYL)|Net Margin VANI (Vivani Medical)|Net Margin xtantmedical.com XTNT|Net Profit Rate NMTC|MODD - Net Margin|Net Profit Rate MYO (Myomo, Inc)|COCH (Envoy Medical, Inc.) - Return on Sales by Net Profit|Vivos Therapeutics, Inc. - Net Profit Rate|Net Margin enVVeno Corp|SINT (Sintx Technologies) - Company Net Profitability|Net Sales Margin TNON|LFWD (Lifeward Ltd.) - Net Profit Rate|autonomix.com - Return on Sales by Net Profit|Company Sales Margin invobioscience.com (IVF)|BBLG - Net Margin|AXNX (Axonics) - Net Return on Sales|Dynatronics Corporation (DYNT) - Net Margin|Net Return on Sales FNA|INVO (INVO Bioscience Inc.) - Net Sales Margin